Impact of Achieving Minimal Disease Activity on Patient-Reported Outcome Measures and Disease Activity Among Patients with Psoriatic Arthritis Treated with Biologic and Targeted Synthetic DMARDs

被引：0
|
作者：
Ogdie, Alexis [1 ]
McLean, Robert [2 ]
Marchese, Maya [2 ]
Blachley, Taylor [2 ]
Anatale-Tardiff, Laura [3 ]
Saffore, Christopher [4 ]
Douglas, Kevin [5 ]
Quach, Danny [5 ]
Mease, Philip [6 ,7 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] CorEvitas LLC, Waltham, MA USA
[3] CorEvitas, Waltham, MA USA
[4] AbbVie, N Chicago, IL 60064 USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Swedish Med Ctr Providence St Joseph Hlth, Seattle, WA USA
[7] Univ Washington, Seattle, WA 98195 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1344
引用
收藏
页码：2798 / 2801
页数：4
相关论文
共 50 条
  • [21] CHANGES IN DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH IXEKIZUMAB IN A REAL-WORLD US COHORT
    Birt, J.
    Tillett, W.
    Cavanaugh, C.
    Jung, Y.
    Vadhariya, A.
    Ross, S.
    Paulus, J.
    Sprabery, A. T.
    Lubrano, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 851 - 852
  • [22] EFFECT OF FATIGUE ON DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES (PROS) IN PATIENTS (PTS) WITH PSORIATIC ARTHRITIS (PSA)
    Vorobyova, L.
    Korotaeva, T.
    Loginova, E.
    Korsakova, Y.
    Gubar, E.
    Tremaskina, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1327 - 1328
  • [23] PROGNOSTIC FACTORS ASSOCIATED WITH ACHIEVING MINIMAL DISEASE ACTIVITY IN EARLY PSORIATIC ARTHRITIS PATIENTS
    Loginova, E.
    Korotaeva, T.
    Gubar, E.
    Glukhova, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 310 - 310
  • [24] OBESITY AND LOWER LIKELIHOOD OF ACHIEVING MINIMAL DISEASE ACTIVITY AND REMISSION IN PSORIATIC ARTHRITIS PATIENTS
    Vallejo-Yague, E.
    Burkard, T.
    Moeller, B.
    Burden, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 860 - 860
  • [25] MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS PREDICTS LOW IMPACT OF DISEASE
    Kasavkar, Ganesh
    Banerjee, Siwalik
    Gullick, Nicola
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1274 - 1275
  • [26] Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
    Kavanaugh, Arthur
    Singh, Rakesh
    Karki, Chitra
    Etzel, Carol J.
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    Griffith, Jenny
    CLINICAL RHEUMATOLOGY, 2018, 37 (08) : 2275 - 2280
  • [27] Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
    Arthur Kavanaugh
    Rakesh Singh
    Chitra Karki
    Carol J. Etzel
    Joel M. Kremer
    Jeffrey D. Greenberg
    Jenny Griffith
    Clinical Rheumatology, 2018, 37 : 2275 - 2280
  • [28] Can the patient-reported outcome instruments determine disease activity in rheumatoid arthritis?
    Durmus, B.
    Altay, Z.
    Baysal, O.
    Ersoy, Y.
    Erdal, A.
    Cevik, R.
    Ardicoglu, O.
    Tekeoglu, I
    Yildirim, K.
    Sarac, A. J.
    Kamanli, A.
    Karatay, S.
    Nas, K.
    Kaya, A.
    Senel, K.
    Gur, A.
    Ugur, M.
    Ozgocmen, S.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (10): : 555 - 561
  • [29] Aging and Psoriatic Arthritis: Disease Activity and Patient Reported Outcomes
    Chachad, N.
    Perin, J.
    Orbai, A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S223 - S223
  • [30] Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity
    Pope, Janet
    Bingham, Clifton O., III
    Fleischmann, Roy M.
    Dougados, Maxime
    Massarotti, Elena M.
    Wollenhaupt, Juergen
    Duncan, Benjamin
    Coteur, Geoffroy
    Weinblatt, Michael E.
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
12345